With patients' well-being in focus and dose reduction as a top priority, Siemens over the past three decades has introduced innovations in the way CT operates and how it is used.
With patients' well-being in focus and dose reduction as a top priority, Siemens over the past three decades has introduced innovations in the way CT operates and how it is used.
In 2005, the company introduced the Somatom Definition dual-source CT (DSCT). Through more than 400 DSCT installations over the past three years, Siemens has redefined the clinical role of CT by doubling temporal resolution, speed, and power. This scanner eliminates the need for beta blockers to reduce heartbeat frequency during CT heart examinations. Another major benefit is the ability to perform functional as well as anatomical imaging. Using dual energy with 10 applications, all cleared by the FDA, makes visible many pathologies that could not previously be detected. In combination with syngo WebSpace, this information can be interactively and instantaneously available to any department in a hospital, as well as to external locations.
In 2007, Siemens continued its evolution of single-source CT with the introduction of the Somatom Definition AS, the first truly adaptive CT scanner. Based on a fundamentally new way to use single-source CT, the Definition AS adapts on the fly to patients and their clinical needs, even the most challenging pediatric, obese, cardiac, or trauma cases. With its Adaptive 4D Spiral, it moves beyond fixed detector limitations to provide full 4D coverage of any organ. In stroke or tumor assessment, this provides invaluable functional information. With its built-in 3D, minimally invasive suite, Somatom Definition AS makes routine and complex procedures noticeably easier.
The road to these scanners was marked by the development of critical components, among them z-Sharp, which in 2003 pushed the boundaries of spatial resolution to a new level, producing routine isotropic resolution of 0.33 mm.
Just as Siemens has pursued advances in spatial and temporal resolution and functional wholeorgan and dual-energy imaging, so have we prioritized minimizing radiation dose. Over the years, Siemens has successfully integrated innovations that drastically reduce radiation dose.
The first giant step was achieved by our introduction of multislice CT in 1998. This was followed by the first ECG-pulsing system in 1999. Two years later, Siemens introduced Care Dose4D, the first completely automated x-ray exposure control. Another quantum improvement was reached with the introduction of DSCT, which drastically reduces cardiac dose to below even the level that can be achieved with coronary catheterization.
The latest Somatom Definition AS innovation in dose reduction is the Adaptive Dose Shield, a tubeside dynamic collimator that eliminates spurious radiation not usable for image reconstruction.
At Siemens research and development departments, we will continue to prioritize dose reduction, assuring both patients and medical personnel the best in medical care with the least possible risk. Siemens' next core innovation will once again make a difference to its customers by making CT exams much healthier for their patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.